Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS EQUITY (DEFICIT) (Details 3)

v3.22.1
STOCKHOLDERS EQUITY (DEFICIT) (Details 3) - $ / shares
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Number of options outstanding 1,721,074    
Weighted average remaining contractual life (in years) 8 years 5 months 26 days    
Number of exercisable options 840,376    
Weighted average exercise price exercisable $ 8.47    
Registered Warrant      
Number of options outstanding 2,975,497 0 0
Weighted average remaining contractual life (in years) 4 years 4 months 20 days    
Number of exercisable options 2,975,497    
Weighted average exercise price exercisable $ 5.50    
Registered Warrant | 5.50      
Exercise price range 5.50    
Number of options outstanding 2,975,497    
Weighted average remaining contractual life (in years) 4 years 4 months 20 days    
Exercise Price Range, Exercisable 5.50    
Number of exercisable options 2,975,497    
Weighted average exercise price exercisable $ 5.50